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Abstract – The aim of the present study was to evaluate the subchronic effects of 3,4-methylenedioxymethamphetamine 
on several oxidative stress markers: index of lipid peroxidation (ILP), superoxide dismutase (SOD) activity, superoxide 
radical (O2
.-) levels, and reduced glutathione (GSH) levels in the frontal cortex, striatum and hippocampus of the rat. The 
study included 64 male Wistar rats (200-250 g). The animals were treated per os with of 5, 10, or 20 mg/kg of 3,4-meth-
ylenedioxymethamphetamine (MDMA) every day for 15 days. The subchronic administration of MDMA resulted in an 
increase in ILP, SOD and O2
.-  , and a decrease in GSH, from which we conclude that oxidative stress was induced in rat 
brain.
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INTRODUCTION
Oxidative  stress  and  oxygen  free  radicals  are 
thought to play an important role in both the acute 
and chronic effects of a number of neurotoxic proc-
esses. Superoxide radicals and hydrogen peroxide are 
produced during electron transport in the mitochon-
dria (Fiaschi et al., 2010). Cells protect themselves 
against reactive oxygen intermediates (ROI) by us-
ing antioxidants such as the superoxide-scavenging 
enzyme superoxide dismutase (SOD) (Touati, 1988), 
catalase and glutathione peroxidase and other nonen-
zymatic agents such as glutathione, other thiols and 
vitamin E (Cadet, 1988).
3,4-Methylenedioxymethamphetamine (MDMA 
or “Ecstasy”), an amphetamine analog, is a popular 
recreational drug of abuse and has been shown to be 
potentially toxic to the serotoninergic nerve termi-
nals of the brains of rodents and humans (Semple et 
al., 1999). MDMA-induced 5-HT toxicity is based 
on long-term biochemical effects such as a decrease 
in the tissue concentration of 5-HT (Turrillazi et al., 
2010) and its major metabolite 5-hydroxyindolacetic 
acid, a decrease in the activity of tryptophan hydrox-
ylase (Stone et al., 1987) and a reduction in the (3H)-
paroxetine-labeled 5-HT reuptake sites (Bataglia et 
al., 1987). The mechanism of MDMA-induced 5-HT 
depletion has been proposed to involve the induction 
of oxidative stress (Sprague et al., 1998). In addition, 
treatments with antioxidants (Barbosa et al., 2012), 
as well as free radical scavengers, are neuroprotective 
against MDMA-induced 5-HT depletion.
Although the acute effect of MDMA on the brain 
has been well documented, the potential functional 1076 IVAN SIMIĆ ET AL.
consequences  associated  with  long-term  MDMA 
administration have not yet been thoroughly evalu-
ated. In the present study, the neurochemical re-
sponses to repeated administration of MDMA were 
evaluated.
MATERIALS AND METHODS
Investigations were made on 64 6 weeks old male 
Wistar rats weighing about 250 g. The rats were di-
vided into four groups (according to drug treatment) 
and  each  group  consisted  of  16  animals.  The  rats 
were housed in Makrolon cages, 4 per cage (Erath, 
FRG). Animals had free access to food and water. 
Average  microclimate  conditions  were  as  follows: 
temperature (22±2°C), relative humidity (60-70%), 
and dark/light cycles (12 h). Food (commercial rat 
diet) and water were not restricted. MDMA was dis-
solved in distilled water and administered perorally 
at 5, 10 and 20 mg/kg once per day for 15 days. The 
control group received the same volume of distilled 
water. The animals were killed by decapitation 15 
days after the treatment. Brain tissues of the ipsilater-
al forebrain cortex, hippocampus and striatum from 
individual animals were quickly isolated on ice and 
homogenized in an ice-cold buffer containing 0.25 
mol sucrose, 1 mM EDTA, 10 mmol K-Na phosphate 
buffer, pH 7.0. Homogenates were centrifuged twice 
at 3 500 rpm for 15 min at 4°C. The supernatant ob-
tained by this procedure was then frozen and stored 
at -70°C (Gurd et al., 1974). 
Protein measurement
The content of protein in the rat brain homogenates 
was measured by the method of Lowry et al. (1974) 
using bovine serum albumin (Sigma) as standard. 
Biochemical analysis
Superoxide  dismutase  (SOD)  activity  was  deter-
mined as inhibition of epinephrine autooxidation at 
480 nm. After adding 10mM of epinephrine (Sigma), 
the  kinetics  were  monitored  in  sodium  carbonate 
buffer (50 mM, pH 10.2; Serva) containing 0.1 mM 
EDTA (Sigma) (Sun et al., 1978).
The superoxide anion content was determined 
by the reduction of nitroblue-tetrazolium (Merck) 
in an alkaline, nitrogen-saturated medium. Analysis 
was performed at 515 nm (Auclair et al., 1985.).
The lipid peroxidation index was measured as 
malondialdehyde  produced  after  stimulated  per-
oxidation  with  0.01  mM  ferrosulfate  (Merck)  and 
0.5 mM ascorbic acid (Serva). Thiobarbituric acid 
reagent  (TBAR),  consisting  of  trichloroacetic  acid 
(Merck),  thiobarbituric  acid  and  HCl,  reacts  with 
malondialdehyde, the final product of polyunsatu-
rated fatty acid peroxidation, measured at 533 nm 
(Villacara et al., 1989).
The content of reduced glutathione (GSH) was 
determined using 5,5-dithiobis-2-nitrobenzoic acid 
(DTNB,  36.9mg  in  10ml  of  methanol)  that  reacts 
with aliphatic thiol compounds in tris-HCl buffer 
(0.4M,  pH-8.9),  producing  a  yellow-colored  p-ni-
trophenol anion. Intensity of the color was used for 
spectrophotometrical measurement of GSH concen-
tration at 412 nm (Anderson, 1986).
Data presentation and analysis
Data are expressed as means ± SD. Differences 
between groups were examined using a Student’s in-
dependent t-test. Statistical significance was accepted 
at p<0.05.
RESULTS
As can be observed in Fig. 1, the daily pero-
ral administration of a MDMA for 15 days caused 
a significant increase in SOD activity in all three 
brain regions examined in the rats. Fig. 2 shows no 
significant  changes  following  administration  of  5 
mg/kg MDMA in the tissue concentration of O2.- 
. The other MDMA-treated groups show increased 
levels of O2.- . In MDMA-treated rats, the levels of 
ILP were significantly elevated relative to those for 
the controls (Fig. 3). MDMA caused slight decreas-
es in GSH activity in the 5 mg/kg group, significant 
decreases in the 20 mg/kg group and no significant 
changes in the 10 mg/kg group (Fig 4).THE SUBCHRONIC EFFECTS OF MDMA 1077
Fig. 1. Effects of methylendioxymetamphetamine on levels on SOD in forebrain cortex, hippocampus and striatum
Fig. 2. Effects of methylendioxymetamphetamine on levels on O2
.-
 in forebrain cortex, hippocampus and striatum1078 IVAN SIMIĆ ET AL.
Fig. 3. Effects of methylendioxymetamphetamine on levels on ILP in forebrain cortex, hippocampus and striatum
Fig. 4. Effects of methylendioxymetamphetamine on levels on GSH in forebrain cortex, hippocampus and striatumTHE SUBCHRONIC EFFECTS OF MDMA 1079
DISCUSSION
Although the exact mechanism of MDMA-induced 
neurotoxicity is unknown, there is increasing evi-
dence  in  support  of  the  hypothesis  that  oxidative 
stress due to the formation of free radicals may be 
involved in MDMA-induced damage to 5-HT ter-
minals. The findings that free-radical scavengers and 
antioxidants attenuate the MDMA-induced depletion 
of 5-HT (Gudelsky, 1996) provide indirect evidence 
of the involvement of free radicals in the mechanism 
of MDMA neurotoxicity.
Several theories have been proposed to explain 
the toxicity of MDMA. Colado et al. (1997) have 
postulated  that  free  radicals  produced  by  MDMA 
are formed within the 5-HT terminal and are gener-
ated by the oxidative quinone metabolites of MDMA 
itself. One possibility is that toxic 5-HT metabolite 
may be transported into the 5-HT axon and produce 
oxidative stress and terminal degeneration (Berger et 
al., 1992).
Excessive extracellular dopamine may give rise 
to the formation of reactive oxygen species or ROS 
(Cadet  et  al.,  1998),  and  the  MDMA-induced  in-
crease in hydroxyl radical formation may simply be 
a consequence of the increase in the extracellular 
concentration of dopamine. Huang et al. (1997) have 
reported  that  the  administration  of  amphetamine 
alone does not increase hydroxyl radical formation. 
These results suggest that the generation of hydroxyl 
radicals is not simply the result of an increase in the 
extracellular concentration of dopamine. Neverthe-
less, there is recent for a role of dopamine in the 
MDMA-induced  generation  of  hydroxyl  radicals, 
as well as the long-term depletion of striatal 5-HT 
(Shankaran et al., 1999). Sprague et al. (1998) have 
speculated that dopamine released by MDMA may 
enter the 5-HT terminal through an activated 5-HT 
transporter and be oxidized by monoamine oxidase-
B enzyme present within the 5-HT terminal, leading 
to the generation of free radicals.
It  was  shown  that  MDMA  administration  de-
creased the cytochrome oxidase complex IV of the 
electron  transport  chain  in  dopamine-rich  areas 
(Burrows et al., 2000) It may be that the MDMA-
induced  release  of  dopamine  compromised  mito-
chondrial  function  because  of  auto-oxidation  of 
dopamine metabolites to form quinones and reactive 
oxygen species. Quinones and ROS have been shown 
to inhibit mitochondrial enzymes (Ben-Schachar et 
al., 1995) and lead to the disruption of mitochondrial 
function and to an increase in intracellular calcium 
levels (Khodrow et al., 1999) and activation of both 
nNOS and eNOS (Stuehr et al., 1992).
The role of cell stress- and apoptosis-associated 
pathways  in  amphetamine  neurotoxicity  was  also 
investigated (Stumm et al., 1999). Expression of the 
immediate early transcription factor, c-jun, and the 
translation  initiation  inhibitor,  p97,  are  restricted 
to the non-methylated DA and MDA analogs and 
thereby to high neurotoxic potential.
Our data suggest that free radicals could be in-
volved in MDMA-induced damage in rats. Over the 
15 days following MDMA treatment, there were sig-
nificant differences between the vehicle and drug-
treated groups
The former (multiple-dose) protocol more reli-
ably produces neurotoxicity. In monkeys that self-
administer MDMA over several months, for a total 
drug exposure similar to a corresponding acute dos-
ing protocol, no signs of neurotoxicity were observed 
(Fantegrossi et al., 2004). The data suggest that a crit-
ical threshold concentration of neurotoxic metabo-
lites must be reached to produce a permanent neu-
rotoxic response, with such a threshold only achiev-
able either at very high doses or after repeated dosing 
regimens over a relatively short period of time.
It is not possible to exclude completely the pos-
sibility that pharmacokinetic tolerance contributes 
to the diminished functional responses to an acute 
injection (Simic et al., 2008) of MDMA following 
repeated administration of the drug. Three under-
lying mechanisms for chronic tolerance to psycho-
active drugs are traditionally described as hepatic/
metabolic, neurochemical and behavioral (Leonard, 1080 IVAN SIMIĆ ET AL.
1997;  Julien,  1998).  Following  its  administration, 
MDMA forms an intermediate metabolite complex 
with CYP2D6, leading to the almost complete loss of 
the enzyme for several days, then gradual recovery 
over the subsequent 2-3 weeks (Heydari et al., 2002). 
In terms of enzymatic induction, a literature review 
uncovered no repeated dose investigations. Also of 
potential concern are the 5-9% of Caucasians defi-
cient in CYP2D6, and it has been suggested that they 
could be particularly susceptible to the adverse effects 
of MDMA (Tucker et al., 1994). Aguirre et al. (1995) 
found that an intensive repeated dose regimen (30 
mg i.p. twice daily over 4 successive days), led to an 
increase in 5-HT1A receptor density in the frontal 
cortex, together with a parallel decrease in 5-HT1A 
receptor  density  in  the  dorsal  raphe  region.  The 
frontal cortex post-synaptic receptor density chang-
es were interpreted as possibly indicating ‘adaptive 
changes to compensate for the loss of serotonin nerve 
terminals’ (also in the hippocampus) (Aguirre et al., 
1995). Because MDMA acutely stimulates 5-HT1A 
autoreceptors in the raphe region, equivalent neu-
roadaptive  mechanisms  were  proposed  to  explain 
the decrease in somatodendritic autoreceptors after 
repeated dosing. Reneman et al. (2002) demonstrat-
ed  a  time-dependent  increase  in  cortical  5-HT2A 
receptor density, which was strongly correlated with 
the extent of MDMA-induced serotonin loss; again, 
this was interpreted as compensatory upregulation.
In  summary,  the  repeated  administration  of 
MDMA resulted in a decrease in the concentration 
of GSH and an increase in the generation of SOD,     
O2.- and ILP in the brain. These data support the con-
clusion that MDMA-induced neurotoxicity involves 
the induction of oxidative stress resulting from an 
increased generation of free radicals and a decreased 
antioxidant capacity of the brain. More studies are 
needed in order to further identify other key physi-
ological and molecular events that are involved in 
the neurotoxic effects of the drug.
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